|
1
|
Kırkıl G: Predictors of mortality in
sarcoidosis. Clin Chest Med. 45:175–183. 2024.PubMed/NCBI View Article : Google Scholar
|
|
2
|
MacSween RNM and Burt AD: Liver pathology
associated with diseases of other organs. in: Pathology of the
Liver. 3rd ed. MacSween RNM, Anthony PP, Scheuer PJ, Burt AD,
Portmann BC Eds. Churchill Livingstone, Hong Kong,
1994:718-719.
|
|
3
|
Hu X, Zou L, Wang S, Zeng T, Li P, Shen Y
and Chen L: Performance of serum angiotensin-converting enzyme in
diagnosing sarcoidosis and predicting the active status of
sarcoidosis: A meta-analysis. Biomolecules. 12(1400)2022.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Vanmaris RMM and Rijkers GT: Biological
role of the soluble interleukin-2 receptor in sarcoidosis.
Sarcoidosis Vasc Diffuse Lung Dis. 34:122–129. 2017.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Chopra A, Kalkanis A and Judson MA:
Biomarkers in sarcoidosis. Expert Rev Clin Immunol. 12:1191–1208.
2016.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Damoiseaux J: The IL-2-IL-2 receptor
pathway in health and disease: The role of the soluble IL-2
receptor. Clin Immunol. 218(108515)2020.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Kanda N, Yamaguchi R, Yamamoto Y,
Matsumura M and Hatakeyama S: Performance of serum soluble
interleukin-2 receptor as a diagnostic marker for lymphoma in
patients with fever. Sci Rep. 13(18784)2023.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Ennaifer R, Ayadi S, Romdhane H, Cheikh M,
Nejma HB, Bougassas W and Hadj NB: Hepatic sarcoidosis: A case
series. Pan Afr Med J. 24(209)2016.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Graf C, Arncken J, Lange CM, Willuweit K,
Schattenberg JM, Seessle J, Lang-Meli J, Böttler T, Dietz J,
Wetzstein N, et al: Hepatic sarcoidosis: Clinical characteristics
and outcome. JHEP Rep. 3(100360)2021.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Lehmuskallio E, Hannuksela M and Halme H:
The liver in sarcoidosis. Acta Med Scand. 202:289–293.
1977.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Baughman RP, Teirstein AS, Judson MA,
Rossman MD, Yeager H Jr, Bresnitz EA, DePalo L, Hunninghake G,
Iannuzzi MC, Johns CJ, et al: Clinical characteristics of patients
in a case control study of sarcoidosis. Am J Respir Crit Care Med.
164 (10 Pt 1):1885–1889. 2001.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Kumar M and Herrera JL: Sarcoidosis and
the Liver. Clin Liver Dis. 23:331–343. 2019.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Devaney K, Goodman ZD, Epstein MS,
Zimmerman HJ and Ishak KG: Hepatic sarcoidosis. Clinicopathologic
features in 100 patients. Am J Surg Pathol. 17:1272–1280.
1993.PubMed/NCBI
|
|
14
|
Moreno-Merlo F, Wanless IR, Shimamatsu K,
Sherman M, Greig P and Chiasson D: The role of granulomatous
phlebitis and thrombosis in the pathogenesis of cirrhosis and
portal hypertension in sarcoidosis. Hepatology. 26:554–560.
1997.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Israel HL, Margolis ML and Rose LJ:
Hepatic granulomatosis and sarcoidosis. Further observations. Dig
Dis Sci. 29:353–356. 1984.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Inoue M, Chiba T, Zen Y, Yokota H, Kanda
T, Ogasawara S, Sugiyama H, Arai M, Kanai F, Ogawa M, et al:
Hepatic sarcoidosis with an increased serum level of immunoglobulin
G4. Intern Med. 51:3095–3098. 2012.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Kikuchi M, Koizumi A, Namisaki T, Asada S,
Oyama M, Tomooka F, Fujimoto Y, Kitagawa K, Kawaratani H and
Yoshiji H: Improvement of liver histology in hepatic sarcoidosis
due to treatment with corticosteroids and ursodeoxycholic acid: A
case report. Clin J Gastroenterol. 17:327–333. 2024.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Modaresi Esfeh J, Culver D, Plesec T and
John B: Clinical presentation and protocol for management of
hepatic sarcoidosis. Expert Rev Gastroenterol Hepatol. 9:349–358.
2015.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Park YJ, Woo HY, Kim MB, Ahn J and Heo J:
Primary hepatic sarcoidosis presenting with cholestatic liver
disease and mimicking primary biliary cholangitis: A case report. J
Yeungnam Med Sci. 39:256–261. 2022.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Sollors J, Schlevogt B, Schmidt HJ, Woerns
MA, Galle PR, Qian Y, Antoni C, Weis CA, Hetjens S, Bergner R, et
al: Management of hepatic sarcoidosis. J Gastrointestin Liver Dis.
31:323–330. 2022.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Kessler A, Mitchell DG, Israel HL and
Goldberg BB: Hepatic and splenic sarcoidosis: Ultrasound and MR
imaging. Abdom Imaging. 18:159–163. 1993.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Gezer NS, Başara I, Altay C, Harman M,
Rocher L, Karabulut N and Seçil M: Abdominal sarcoidosis:
Cross-sectional imaging findings. Diagn Interv Radiol. 21:111–117.
2015.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Karaosmanoğlu AD, Onur MR, Saini S, Taberi
A and Karcaaltincaba M: Imaging of hepatobiliary involvement in
sarcoidosis. Abdom Imaging. 40:3330–3337. 2015.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Studdy PR, Bird R, Neville E and James DG:
Biochemical findings in sarcoidosis. J Clin Pathol. 33:528–533.
1980.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Jacquet-Francillon N, Dijoud F, Karlin L,
Dietz M, Flaus A and Tordo J: Randall-Type monoclonal
immunoglobulin deposition disease in bone scintigraphy. Clin Nucl
Med. 48:e611–e613. 2023.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Hirabayashi R, Nakayama H, Yahaba M,
Yamanashi H and Kawasaki T: Japanese TB Clinical Practice Guideline
Systematic Review Task Force. Utility of interferon-gamma releasing
assay for the diagnosis of active tuberculosis in children: A
systematic review and meta-analysis. J Infect Chemother.
30:516–525. 2024.PubMed/NCBI View Article : Google Scholar
|
